Literature DB >> 18408749

Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC.

K Unger1, E Malisch, G Thomas, H Braselmann, A Walch, G Jackl, P Lewis, E Lengfelder, T Bogdanova, J Wienberg, H Zitzelsberger.   

Abstract

The aim of this study is to investigate additional genetic alterations in papillary thyroid carcinomas (PTCs) with known RET/PTC rearrangements. We applied array-based comparative genomic hybridization (array CGH) to 33 PTC (20 PTC from adults, 13 post-Chernobyl PTC from children) with known RET/PTC status. Principal component analysis and hierarchical cluster analysis identified cases with similar aberration patterns. Significant deviations between tumour-groups were obtained by statistical testing (Fisher's exact test in combination with Benjamini-Hochberg FDR-controlling procedure). FISH analysis on FFPE sections was applied to validate the array CGH data. Deletions were found more frequently in RET/PTC-positive and RET/PTC-negative tumours than amplifications. Specific aberration signatures were identified that discriminated between RET/PTC-positive and RET/PTC-negative cases (aberrations on chromosomes 1p, 3q, 4p, 7p, 9p/q, 10q, 12q, 13q and 21q). In addition, childhood and adult RET/PTC-positive cases differ significantly for a deletion on the distal part of chromosome 1p. There are additional alterations in RET/PTC-positive tumours, which may act as modifiers of RET activation. In contrast, alterations in RET/PTC-negative tumours indicate alternative routes of tumour development. The data presented serve as a starting point for further studies on gene expression and function of genes identified in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408749     DOI: 10.1038/onc.2008.99

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Amplification of thymosin beta 10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas.

Authors:  Liliána Z Fehér; Gábor Pocsay; László Krenács; Agnes Zvara; Enikő Bagdi; Réka Pocsay; Géza Lukács; Ferenc Győry; Andrea Gazdag; Erzsébet Tarkó; László G Puskás
Journal:  Pathol Oncol Res       Date:  2011-12-11       Impact factor: 3.201

Review 2.  Integrating research on thyroid cancer after Chernobyl--the Chernobyl Tissue Bank.

Authors:  G A Thomas; J A Bethel; A Galpine; W Mathieson; M Krznaric; K Unger
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-02-22       Impact factor: 4.126

3.  Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation.

Authors:  Julia Hess; Gerry Thomas; Herbert Braselmann; Verena Bauer; Tatjana Bogdanova; Johannes Wienberg; Horst Zitzelsberger; Kristian Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-23       Impact factor: 11.205

4.  Somatic amplifications and deletions in genome of papillary thyroid carcinomas.

Authors:  Nadia Passon; Elisa Bregant; Marialuisa Sponziello; Maria Dima; Francesca Rosignolo; Cosimo Durante; Marilena Celano; Diego Russo; Sebastiano Filetti; Giuseppe Damante
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

5.  Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American Cohort.

Authors:  Martin Selmansberger; Herbert Braselmann; Julia Hess; Tetiana Bogdanova; Michael Abend; Mykola Tronko; Alina Brenner; Horst Zitzelsberger; Kristian Unger
Journal:  Carcinogenesis       Date:  2015-08-29       Impact factor: 4.944

Review 6.  Multiple Endocrine Neoplasia: Genetics and Clinical Management.

Authors:  Jeffrey A Norton; Geoffrey Krampitz; Robert T Jensen
Journal:  Surg Oncol Clin N Am       Date:  2015-07-27       Impact factor: 3.495

7.  Genetic copy number alterations and IL-13 expression differences in papillary thyroid cancers and benign nodules.

Authors:  ZeFei Zhao; Qing Wei; Yongju Zhao; Fukang Sun; Xiaolong Jin; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2009-06-09       Impact factor: 3.633

8.  Delineating chromosomal breakpoints in radiation-induced papillary thyroid cancer.

Authors:  Heinz-Ulrich G Weier; Yuko Ito; Johnson Kwan; Jan Smida; Jingly F Weier; Ludwig Hieber; Chun-Mei Lu; Lars Lehmann; Mei Wang; Haig J Kassabian; Hui Zeng; Benjamin O'Brien
Journal:  Genes (Basel)       Date:  2011-09-01       Impact factor: 4.096

9.  Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization.

Authors:  Masahiro Oikawa; Koh-ichiro Yoshiura; Hisayoshi Kondo; Shiro Miura; Takeshi Nagayasu; Masahiro Nakashima
Journal:  Radiat Oncol       Date:  2011-12-07       Impact factor: 3.481

10.  Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Authors:  Willem E Corver; Dina Ruano; Karin Weijers; Wietske C E den Hartog; Merlijn P van Nieuwenhuizen; Noel de Miranda; Ronald van Eijk; Anneke Middeldorp; Ekaterina S Jordanova; Jan Oosting; Ellen Kapiteijn; Guido Hovens; Jan Smit; Tom van Wezel; Hans Morreau
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.